Quidel has announced that it will be partnering with Parkhurst NuVision (PNV) to become the first ophthalmic clinic in the nation to offer on-site rapid COVID-19 testing for employees, patients, and other doctors in the San Antonio area.

“Throughout the pandemic, getting access to testing has been immensely vital, yet almost as difficult,” says PNV Clinic Director Dr. Roberto Saenz. “We knew that if we wanted testing to be more widely available, then we’d need to help lead the effort.” Shawn Mullen, head of Strategic Accounts was equally excited, “The ophthalmology and optometry community should be able to offer these tests to their staff and patients as well.”

Quidel has partnered with many medical practices across the country to increase access, and Parkhurst NuVision is the first ophthalmic facility to join the ranks. Quidel and Parkhurst NuVision are gearing up to roll out testing in the office setting, benefiting San Antonio eye doctors as well as patients and employees of Parkhurst NuVision.

Quidel representatives are calling it a “trailblazer moment” and Dr. Greg Parkhurst is proud to agree. Dr. Greg Parkhurst, chief executive officer at PNV said, “Our team is known for striving to be at the forefront of the next best practice, procedure, or advancement. Pursuing this opportunity to serve our community and care for each other fits perfectly with who we are and the kind of clinic we strive to be. We are also proud to now be approved by the State of Texas as a COVID-19 vaccine provider.”

Testing start dates, vaccine availabilities, and other details of the plan will be announced on Parkhurst NuVision and Quidel platforms soon. For questions about the partnership or other plan inquiries, call (210) 585-2020.